182 related articles for article (PubMed ID: 35275317)
1. Central nervous system adverse events after ChAdOx1 vaccination.
Maramattom BV; Lotlikar RS; Sukumaran S
Neurol Sci; 2022 Jun; 43(6):3503-3507. PubMed ID: 35275317
[TBL] [Abstract][Full Text] [Related]
2. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.
Jarius S; Bieber N; Haas J; Wildemann B
J Neurol; 2022 Oct; 269(10):5198-5212. PubMed ID: 35737110
[TBL] [Abstract][Full Text] [Related]
3. Acute disseminated encephalomyelitis and transverse myelitis following COVID-19 vaccination - A self-controlled case series analysis.
Morgan HJ; Clothier HJ; Sepulveda Kattan G; Boyd JH; Buttery JP
Vaccine; 2024 Apr; 42(9):2212-2219. PubMed ID: 38350771
[TBL] [Abstract][Full Text] [Related]
4. Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222).
Román GC; Gracia F; Torres A; Palacios A; Gracia K; Harris D
Front Immunol; 2021; 12():653786. PubMed ID: 33981305
[TBL] [Abstract][Full Text] [Related]
5. Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - A risk-benefit analysis for people < 60 years in Australia.
MacIntyre CR; Veness B; Berger D; Hamad N; Bari N
Vaccine; 2021 Aug; 39(34):4784-4787. PubMed ID: 34272095
[TBL] [Abstract][Full Text] [Related]
6. Postvaccinal Encephalitis after ChAdOx1 nCov-19.
Zuhorn F; Graf T; Klingebiel R; Schäbitz WR; Rogalewski A
Ann Neurol; 2021 Sep; 90(3):506-511. PubMed ID: 34324214
[TBL] [Abstract][Full Text] [Related]
7. Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: A population-based cohort study of 46 million adults in England.
Whiteley WN; Ip S; Cooper JA; Bolton T; Keene S; Walker V; Denholm R; Akbari A; Omigie E; Hollings S; Di Angelantonio E; Denaxas S; Wood A; Sterne JAC; Sudlow C;
PLoS Med; 2022 Feb; 19(2):e1003926. PubMed ID: 35192597
[TBL] [Abstract][Full Text] [Related]
8. Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency.
Krzywicka K; Heldner MR; Sánchez van Kammen M; van Haaps T; Hiltunen S; Silvis SM; Levi M; Kremer Hovinga JA; Jood K; Lindgren E; Tatlisumak T; Putaala J; Aguiar de Sousa D; Middeldorp S; Arnold M; Coutinho JM; Ferro JM
Eur J Neurol; 2021 Nov; 28(11):3656-3662. PubMed ID: 34293217
[TBL] [Abstract][Full Text] [Related]
9. The risk of acute disseminated encephalomyelitis (ADEM) following covid-19 vaccination in England: A self-controlled case-series analysis.
Stowe J; Lopez-Bernal J; Andrews N
Hum Vaccin Immunother; 2024 Dec; 20(1):2311969. PubMed ID: 38299507
[TBL] [Abstract][Full Text] [Related]
10. Thrombosis with thrombocytopenia after AZD1222 (ChAdOx1 nCov-19) vaccination: Case characteristics and associations.
Laffan MA; Rees S; Yadavalli M; Ferstenberg LB; Kumar Shankar N; Medin J; Foskett N; Arnold M; Gomes da Silva H; Bhuyan P; Nord M
Vaccine; 2022 Sep; 40(38):5585-5593. PubMed ID: 35989136
[TBL] [Abstract][Full Text] [Related]
11. Thrombosis with thrombocytopenia syndrome (TTS) following adenovirus vector COVID-19 vaccination in Canada.
Procter TD; Ogasawara H; Spruin S; Wijayasri S; Abraham N; Blaser C; Hutchings K; Shaw A; Ogunnaike-Cooke S
Vaccine; 2023 Nov; 41(46):6802-6809. PubMed ID: 37806804
[TBL] [Abstract][Full Text] [Related]
12. Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis.
Li X; Raventós B; Roel E; Pistillo A; Martinez-Hernandez E; Delmestri A; Reyes C; Strauss V; Prieto-Alhambra D; Burn E; Duarte-Salles T
BMJ; 2022 Mar; 376():e068373. PubMed ID: 35296468
[TBL] [Abstract][Full Text] [Related]
13. Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platform.
Walker JL; Schultze A; Tazare J; Tamborska A; Singh B; Donegan K; Stowe J; Morton CE; Hulme WJ; Curtis HJ; Williamson EJ; Mehrkar A; Eggo RM; Rentsch CT; Mathur R; Bacon S; Walker AJ; Davy S; Evans D; Inglesby P; Hickman G; MacKenna B; Tomlinson L; Ca Green A; Fisher L; Cockburn J; Parry J; Hester F; Harper S; Bates C; Evans SJ; Solomon T; Andrews NJ; Douglas IJ; Goldacre B; Smeeth L; McDonald HI
Vaccine; 2022 Jul; 40(32):4479-4487. PubMed ID: 35715350
[TBL] [Abstract][Full Text] [Related]
14. A disproportionality analysis for the association of central nervous system demyelinating diseases with COVID-19 vaccination using the World Health Organization pharmacovigilance database.
Kim JE; Park J; Song TJ
Mult Scler; 2022 Nov; 28(13):2112-2123. PubMed ID: 35822296
[TBL] [Abstract][Full Text] [Related]
15. ADEM after ChAdOx1 nCoV-19 vaccine: A case report.
Rinaldi V; Bellucci G; Romano A; Bozzao A; Salvetti M
Mult Scler; 2022 Jun; 28(7):1151-1154. PubMed ID: 34590902
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing adverse events following immunization with AZD1222 in Vietnamese adults during first half of 2021.
Tran VN; Nguyen HA; Le TTA; Truong TT; Nguyen PT; Nguyen TTH
Vaccine; 2021 Oct; 39(44):6485-6491. PubMed ID: 34607748
[TBL] [Abstract][Full Text] [Related]
17. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review.
Sharifian-Dorche M; Bahmanyar M; Sharifian-Dorche A; Mohammadi P; Nomovi M; Mowla A
J Neurol Sci; 2021 Sep; 428():117607. PubMed ID: 34365148
[TBL] [Abstract][Full Text] [Related]
18. Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil.
Mouta Nunes de Oliveira P; Mendes-de-Almeida DP; Bertollo Gomes Porto V; Crespo Cordeiro C; Vitiello Teixeira G; Saraiva Pedro R; Roberto Gomes Takey P; Kegele Lignani L; Reis Xavier J; Cardoso Doria da Gama V; Amorim Filho L; Emoingt Furtado B; Santa Maria A; Dahrug Barros T; Neves Waite Freitas L; Dos Santos Pereira T; Lima Abreu D; Bernardes Ramos M; Gabe C; Arnold D; William Smith J; Nazy I; Lourdes de Sousa Maia M;
Vaccine; 2022 Aug; 40(33):4788-4795. PubMed ID: 35779962
[TBL] [Abstract][Full Text] [Related]
19. Central nervous system immune-related disorders after SARS-CoV-2 vaccination: a multicenter study.
Vogrig A; Tartaglia S; Dentoni M; Fabris M; Bax F; Belluzzo M; Verriello L; Bagatto D; Gastaldi M; Tocco P; Zoccarato M; Zuliani L; Pilotto A; Padovani A; Villagrán-García M; Davy V; Gigli GL; Honnorat J; Valente M
Front Immunol; 2024; 15():1344184. PubMed ID: 38375477
[TBL] [Abstract][Full Text] [Related]
20. Surveillance on Adverse Events Following COVISHIELD (ChAdOx1 nCoV-19) vaccination in Goa, India: An Observational Study.
Jose D; Dhupdale N; Cacodcar JA; Kamat U
Curr Drug Saf; 2023; 18(4):516-527. PubMed ID: 35927820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
